Françoise Bouhour

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Ovarian Failure Related to Eukaryotic Initiation Factor 2B Mutations

Anne Fogli, Diana Rodriguez, Éléonore Eymard-Pierre et al. · The American Journal of Human Genetics · 2003 · 196 citations · Full text

Medicine, Genetics, Molecular Biology +14

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Benedikt Schoser, Mark Roberts, Barry J. Byrne et al. · The Lancet Neurology · 2021 · 132 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +3

Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases

Pierre Labauge, Lætitia Horzinski, Xavier Ayrignac et al. · Brain · 2009 · 126 citations · Full text

Medicine, Neurology, Neuroscience +17

Granulomatous myositis: A clinical study of thirteen cases

Karine Le Roux, Nathalie Streichenberger, Christophe Vial et al. · Muscle & Nerve · 2006 · 94 citations

Medicine, Immunology, Internal Medicine +10